The enumeration of CD34+ cells by flow cytometry is commonly employed
to assess progenitor/stem cell numbers in peripheral blood, cord blood
, and apheresis products used for peripheral blood stem cell transplan
tation (PBSCT). Until recently, the enumeration of CD34+ cells has evo
lved in the absence of any procedural guidelines or quality assurance
programs. We established a voluntary quality assurance for stem cell e
numeration (QASE) program for Canadian laboratories involved in PBSCT.
The goals of this study were 1) to survey current flow cytometric pro
cedures for CD34 enumeration; 2) to evaluate inter-institutional repro
ducibility of currently employed assays; and 3) to evaluate the impact
of adoption of a common method on inter-laboratory variability. Fourt
een to nineteen laboratories participated in this program by enumerati
ng CD34+ cells in shared cord blood samples. The survey showed a wide
variation in flow cytometric methodology which in part contributed to
the wide range in results obtained between different centres. Major di
fferences in methodology included the number of events counted, use of
isotype control and gating strategy. Participation in this program an
d adoption of a common methodology increased level of agreement for an
y given result although this trend did not reach statistical significa
nce (P = 0.13). The results of this survey emphasize the need for a qu
ality assurance program for stem cell enumeration by flow cytometry. (
C) 1997 Wiley-Liss, Inc.